ReviewCurrent hematologic malignancy reports2016
CD30 and CD30-Targeted Therapies in Hodgkin Lymphoma and Other B cell Lymphomas.
Geetika Bhatt et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ReviewCurrent hematologic malignancy reports2016
Geetika Bhatt et al.PubMed ↗Publisher ↗
No numbers read from the abstract.